F. Frappier et al., BISBENZYLISOQUINOLINES AS MODULATORS OF CHLOROQUINE RESISTANCE IN PLASMODIUM-FALCIPARUM AND MULTIDRUG-RESISTANCE IN TUMOR-CELLS, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1476-1481
Ten naturally occurring bisbenzylisoquinolines (BBIQ) and two dihydro
derivatives belonging to five BBIQ subgroups were evaluated in vitro f
or their ability to inhibit Plasmodium falciparum growth and, in drug
combination, to reverse the resistance to chloroquine of strain FcB1.
The same alkaloids were also assessed in vitro for their potentiating
activity against vinblastine with the multidrug-resistant clone CCRF-C
EM/VLB, established from lymphoblastic acute leukemia, Three of the BB
IQ tested had 50% inhibitory concentrations of less than 1 mu M. The m
ost potent antimalarial agent was cocsoline (50% inhibitory concentrat
ion, 0.22 mu M). Regarding the chloroquine-potentiating effect, fangch
inoline exhibited the highest biological activity whereas the remainin
g compounds displayed either antagonistic or slight synergistic effect
s, Against the multidrug-resistant cancer cell line, fangchinoline was
also by far the most active compound, Although there were clear diffe
rences between the activities of tested alkaloids, no relevant structu
re-activity relationship could be established, Nevertheless, fangchino
line appears to be a new biochemical tool able to help in the comprehe
nsion of the mechanism of both chloroquine resistance in P, falciparum
and multidrug resistance in tumor cells.